Cellectis Ownership | Who Owns Cellectis?
Cellectis Ownership Summary
Cellectis is owned by 11.70% institutional investors, 3.85% insiders, and 84.45% retail investors. Long focus capital management is the largest institutional shareholder, holding 4.70% of CLLS shares. American Funds SMALLCAP World A is the top mutual fund, with 1.85% of its assets in Cellectis shares.
CLLS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Cellectis | 11.70% | 3.85% | 84.45% |
| Sector | Healthcare Stocks | 487.91% | 11.08% | -398.99% |
| Industry | Biotech Stocks | 307.10% | 11.11% | -218.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Long focus capital management | 4.72M | 4.70% | $7.12M |
| Ubs asset management americas | 1.44M | 1.44% | $2.59M |
| Millennium management | 534.55K | 0.53% | $962.19K |
| Ubs group | 229.08K | 0.23% | $412.35K |
| Macquarie group | 226.88K | 0.23% | $408.00K |
| Lpl financial | 91.79K | 0.13% | $171.64K |
| Morgan stanley | 86.33K | 0.12% | $161.43K |
| First affirmative financial network | 25.86K | 0.03% | $46.55K |
| Wells fargo & company/mn | 24.59K | 0.02% | $44.26K |
| Bnp paribas arbitrage, snc | 22.40K | 0.02% | $40.32K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Long focus capital management | 4.72M | 0.27% | $7.12M |
| First affirmative financial network | 25.86K | 0.03% | $46.55K |
| Ubs asset management americas | 1.44M | 0.00% | $2.59M |
| Millennium management | 534.55K | 0.00% | $962.19K |
| Pom investment strategies | 495.00 | 0.00% | $755.00 |
| Macquarie group | 226.88K | 0.00% | $408.00K |
| Harbour investments | 4.50K | 0.00% | $6.86K |
| Ubs group | 229.08K | 0.00% | $412.35K |
| Lpl financial | 91.79K | 0.00% | $171.64K |
| Baillie gifford | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Millennium management | 534.55K | 0.00% | 534.55K |
| Ubs group | 229.08K | 0.00% | 229.08K |
| Wells fargo & company/mn | 24.59K | - | 12.50K |
| Lpl financial | 91.79K | 0.00% | 10.44K |
| Jpmorgan chase | 5.57K | - | 5.49K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Capital investors | - | - | -1.85M |
| Principal financial group | - | - | -411.80K |
| Kbc group nv | - | - | -163.45K |
| Baillie gifford | - | - | -139.05K |
| Oppenheimer | - | - | -133.89K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Millennium management | 534.55K | 0.00% | 534.55K | $962.19K |
| Ubs group | 229.08K | 0.00% | 229.08K | $412.35K |
| Raymond james financial | 1.13K | - | 1.13K | $1.73K |
Sold Out
| Holder | Change |
|---|---|
| Financial gravity asset management | -1.00 |
| Toronto dominion bank | -31.00 |
| Frg family wealth advisors | -80.00 |
| Qube research | -112.00 |
| Old point trust & financial services n a | -250.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 22 | -18.52% | 11,737,843 | -13.71% | 11 | 6.33% | 7 | -22.22% | 7 | -12.50% |
| Mar 31, 2025 | 27 | -12.90% | 13,602,212 | 6.61% | 13 | 8.36% | 9 | -25.00% | 8 | 33.33% |
| Dec 31, 2024 | 20 | -31.03% | 5,664,103 | -42.00% | 5 | 5.94% | 8 | 33.33% | 5 | -28.57% |
| Sep 30, 2024 | 29 | -3.33% | 9,766,379 | -0.06% | 9 | 5.27% | 6 | -25.00% | 7 | - |
| Jun 30, 2024 | 30 | -6.25% | 9,772,626 | -0.83% | 13 | 4.33% | 8 | -33.33% | 7 | 40.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| American Funds SMALLCAP World A | 1.85M | 1.85% | - |
| UBS (Lux) Digital Health Equity SB USD | 1.44M | 1.44% | - |
| UBS Lux Dgtl Hlth Eq Fd seeding P acc | 1.30M | 1.30% | - |
| Principal U.S. Small Cap Equity | 289.60K | 0.29% | -4.40K |
| Delaware Healthcare I | 226.88K | 0.23% | - |
| Macquarie Healthcare I | 226.88K | 0.23% | - |
| Galileo - Biotech Innovation Fund S USD | 226.07K | 0.23% | - |
| Principal SmallCap R5 | 199.15K | 0.20% | -90.45K |
| Baillie Gifford Global Discovery A Acc | 147.53K | 0.15% | -1.93K |
| Vanguard International Explorer Inv | 122.03K | 0.12% | - |
CLLS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools